ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - paricalcitol - תמיסה להזרקה - paricalcitol 5 mcg/ml - paricalcitol - paricalcitol - paricalcitol is indicated for the prevention and treatment of secondary hyperparathyrodism associated with chronic renal failure.

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - paricalcitol - קפסולות - paricalcitol 1 mcg - paricalcitol - paricalcitol - zemplar is indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal insufficiency (chronic kidney disease stage 3 and 4 ) patients and chronic renal failure (chronic kidney disease stage 5) patients on haemodialysis or peritoneal dialysis.

ישראל - עברית - Ministry of Health

genmedix , israel - calcitonin salmon; calcitonin salmon - תמיסה להזרקה - calcitonin salmon 100 iu/ml; calcitonin salmon 100 iu/ml - calcitonin (salmon synthetic) - calcitonin (salmon synthetic) - paget's disease, post menopausal osteoporosis, hypercalcemia.

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - paricalcitol - קפסולות רכות - paricalcitol 1 mcg - paricalcitol

ישראל - עברית - Ministry of Health

inovamed ltd - paricalcitol - תמיסה להזרקה - paricalcitol 0.005 mg/ml - paricalcitol

ישראל - עברית - Ministry of Health

lapidot medical import and marketing ltd - paricalcitol - תמיסה להזרקה - paricalcitol 5 mcg / 1 ml - paricalcitol

ישראל - עברית - Ministry of Health

unipharm ltd, israel - paricalcitol - תמיסה להזרקה - paricalcitol 0.005 mg / 1 ml - paricalcitol

ישראל - עברית - Ministry of Health

tzamal bio-pharma ltd - calcitonin salmon 200 iu/dose - nasal spray - calcitonin (salmon synthetic) - fortical® nasal spray is indicated for:postmenopausal osteoporosis – fortical® calcitonin-salmon (rdna origin) nasal spray isindicated for the treatment of postmenopausal osteoporosis in women greater than 5 yearspostmenopause with low bone mass relative to healthy premenopausal women. use of fortical®calcitonin-salmon (rdna origin) nasal spray is recommended in conjunction with an adequatecalcium (at least 1000 mg elemental calcium per day) and vitamin d (400 international units perday) intake to retard the progressive loss of bone mass. the evidence of efficacy for calcitoninsalmonis based on increases in spinal bone mineral density (bmd) observed in clinical trials

ישראל - עברית - Ministry of Health

neopharm ltd - tacalcitol 4.17 mcg/g - ointment - tacalcitol - psoriasis vulgaris. the treatment should not exceed consecutive period of 8 weeks at a maximum of 2 such periods in 12 months

ישראל - עברית - Ministry of Health

novartis pharma services ag - calcitonin salmon 2200 iu/ml - solution - calcitonin (salmon synthetic) - bone pain associated with osteolysis due to malignancies. paget's disease of bone only in patients who do not respond to alternative treatments or for whom such treatments are not suitable. neurodystrophic disorders.